Failure Analysis Of Cardiovascular Technologies, is categorized under Cardiologists in Boca Raton, FL and active since 2008.
Failure Analysis Of Cardiovascular Technologies, was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Cardiologists business, which does work in the B2C market, and is classified as a Cardiologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Anthony C Moreno at the company’s single location by writing to 179 Nw Emerson Place, Boca Raton, Florida FL 33432 or by phoning (561) 756-9588. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Failure Analysis Of Cardiovascular Technologies, |
| Contact Person: | Anthony C Moreno |
| Address: | 179 Nw Emerson Place, Boca Raton, Florida 33432 |
| Phone Number: | (561) 756-9588 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Cardiologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Failure Analysis Of Cardiovascular Technologies, was started in 2008 to provide professional Cardiologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Anthony C Moreno for inquiries that concern Failure Analysis Of Cardiovascular Technologies, by calling the company number (561) 756-9588, as your correspondence is most welcome. Additionally, the physical location of the single location of Failure Analysis Of Cardiovascular Technologies, can be found at the coordinates 26.34613,-80.08385 as well as the street address 179 Nw Emerson Place in Boca Raton, Florida 33432.
For its online presence, you may visit Failure Analysis Of Cardiovascular Technologies,’s website at and engage with its social media outlets through on Twitter and on Facebook.